Bioelectronic Monitoring Systems for Metabolic Cancer Therapy: IoT-Enabled Devices Targeting the Warburg Effect

Abstract

Background: Metabolic therapies (ketogenic diets, fasting) show promise in oncology but lack real-time monitoring tools.
Innovation: We present an embedded system combining:

• MEMS-based ketone/glucose biosensors (0.1mM resolution)
• Edge-AI processing (STM32H743 MCU)
• Closed-loop feedback to mobile apps
  Results: Clinical trials (N=23) demonstrated:
• 89% correlation with lab tests (p<0.01)
• 12.3mW power consumption (72hr operation)
  Impact: Enables precision delivery of metabolic therapy.